FDA
-
-
-
-
-
-
-
LexaGene Receives $3.6M from the Exercise of Warrants
-
-
-
-
-
-
-
LexaGene Introduces its Commercial Product MiQLab™
-
-
-
-
-
-
-
LexaGene’s Analyzer is Designed to Detect Pathogens such as the Novel Coronavirus to Help Avert a Pandemic
-
-
-
-
-
-
-
LexaGene Names Medical Device Veteran Joseph Caruso to Board of Directors
323,901 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

